
Sign up to save your podcasts
Or


In this thrilling episode, we uncover Nvidia's significant injection of $50 million into Recursion, the AI-driven drug discovery firm. Explore the profound impact of this strategic investment as it propels the frontiers of pharmaceutical research and revolutionizes the healthcare sector. Join us for an in-depth look at the dynamic synergy between technology and drug discovery in this captivating discussion!
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By Jaeden SchaferIn this thrilling episode, we uncover Nvidia's significant injection of $50 million into Recursion, the AI-driven drug discovery firm. Explore the profound impact of this strategic investment as it propels the frontiers of pharmaceutical research and revolutionizes the healthcare sector. Join us for an in-depth look at the dynamic synergy between technology and drug discovery in this captivating discussion!
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.